Two Sigma Advisers »

Lava Therapeutics Nv shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Lava Therapeutics Nv (LVTX) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Lava Therapeutics Nv

Tip: Access up to 7 years of quarterly data

All positions including Lava Therapeutics Nv held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lava Therapeutics Nv by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $56k 17k 3.33

More positions owned by Two Sigma Advisers

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Paypal Holdings (PYPL)
Mastercard Incorporated Cl A (MA)
Netflix (NFLX)
Micron Technology (MU)
Bristol Myers Squibb (BMY)
Crowdstrike Hldgs Cl A (CRWD)
Eli Lilly & Co. (LLY)
Wal-Mart Stores (WMT)

View all positions for Two Sigma Advisers

Top funds holding Lava Therapeutics Nv

Redmile Group
Bruce & Co
Sphera Funds Management
Walleye Trading Advisors
Falcon Edge Capital
Two Sigma Investments
Pnc Financial Services
Citadel Advisors
Millennium Management
Schonfeld Strategic Advisors
Susquehanna International
Two Sigma Advisers
Bank of America Corporation
Pathway Financial Advisors
Two Sigma Securities

View all funds holding Lava Therapeutics Nv